pSivida CEO Invited To Speak At Surfaces In BioMaterials Foundation’s BioInterface 2015 Annual Symposium

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced Dr. Paul Ashton, president and CEO of pSivida Corp., will speak at the BioInterface 2015 Annual Symposium of the Surfaces in BioMaterials Foundation being held September 21-23 in Scottsdale, Arizona. Dr. Ashton will speak during the Ophthalmic Drug Delivery Session on Tuesday, September 22 and will address “Idea to Product in Ophthalmic Sustained Release.” Other participants in this session include speakers from Genentech and Allergan, among others. The session is sponsored by Ora, Inc.

Help employers find you! Check out all the jobs and post your resume.